Literature DB >> 22173964

Bilateral deep brain stimulation for cervical dystonia in patients with previous peripheral surgery.

Hans-Holger Capelle1, Christian Blahak, Christoph Schrader, Hansjörg Baezner, Marwan I Hariz, Tommy Bergenheim, Joachim K Krauss.   

Abstract

BACKGROUND: There are no data available concerning whether patients with cervical dystonia who have recurrent or new symptoms after peripheral denervation surgery benefit similarly from pallidal deep brain stimulation compared with patients who receive primarily pallidal stimulation.
METHODS: Data on 7 cervical dystonia patients with recurrent or progressive dystonia after peripheral denervation who underwent pallidal stimulation were prospectively collected. Deep brain stimulation was performed in Mannheim/Hannover, Germany, or in Umea, Sweden. To the subgroup from Mannheim/Hannover, a second group of patients without previous peripheral surgery was matched. Assessments included the Toronto Western Spasmodic Torticollis Rating Scale and the Burke-Fahn-Marsden dystonia rating scale, as well as the Tsui scale in the Swedish patients.
RESULTS: The 4 patients from Mannheim/Hannover experienced sustained improvement from pallidal stimulation by a mean of 57.5% according to the Toronto Western Spasmodic Torticollis Rating Scale (P < .05) and by a mean of 69.5% according to the Burke-Fahn-Marsden dystonia rating scale (P < .05) at long-term follow-up of 40.5 months. The patients from Umea had a mean Tsui score of 7 prior to surgery and a mean score of 3 at the mean follow-up of 8 months (62.5%). In the matched group the Toronto Western Spasmodic Torticollis Rating Scale improved by 58.8% and the Burke-Fahn-Marsden dystonia rating scale by 67% (P < .05) at long-term follow-up (mean, 41.5 months).
CONCLUSIONS: Patients who had prior peripheral surgery for cervical dystonia experience improvement from subsequent pallidal stimulation that is comparable to that of de novo patients.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 22173964     DOI: 10.1002/mds.24022

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

Review 1.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 2.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  Selective peripheral denervation: comparison with pallidal stimulation and literature review.

Authors:  Maria Fiorella Contarino; Pepijn Van Den Munckhof; Marina A J Tijssen; Rob M A de Bie; D Andries Bosch; P Richard Schuurman; Johannes D Speelman
Journal:  J Neurol       Date:  2013-11-21       Impact factor: 4.849

4.  Comparative characterization of single cell activity in the globus pallidus internus of patients with dystonia or Tourette syndrome.

Authors:  Mesbah Alam; Kerstin Schwabe; Götz Lütjens; H Holger Capelle; Mihai Manu; Christof von Wrangel; Kirsten Müller-Vahl; Christoph Schrader; Dirk Scheinichen; Christian Blahak; Hans E Heissler; Joachim K Krauss
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

5.  Selective peripheral denervation for cervical dystonia: long-term follow-up.

Authors:  A Tommy Bergenheim; Erik Nordh; Eva Larsson; Marwan I Hariz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-31       Impact factor: 10.154

Review 6.  Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe.

Authors:  Marenka Smit; Alberto Albanese; Monika Benson; Mark J Edwards; Holm Graessner; Michael Hutchinson; Robert Jech; Joachim K Krauss; Francesca Morgante; Belen Pérez Dueñas; Richard B Reilly; Michele Tinazzi; Maria Fiorella Contarino; Marina A J Tijssen
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.